SELLAS Life Sciences Group, Inc. (SLS)

13.86 +0.16 (+1.17%) USD  |  NASDAQ  |  Sep 04, 16:00
13.90 +0.04 (+0.29%) Pre-Market: 20:00
More

SELLAS Life Sciences Group SG&A Expense (TTM) : 14.87M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2026 14.87M
March 31, 2026 13.52M
December 31, 2025 12.25M
September 30, 2025 11.21M
June 30, 2025 11.31M
March 31, 2025 10.74M
December 31, 2024 12.42M
September 30, 2024 13.02M
June 30, 2024 13.60M
March 31, 2024 14.29M
December 31, 2023 13.86M
September 30, 2023 14.38M
June 30, 2023 13.70M
March 31, 2023 13.66M
December 31, 2022 12.58M
September 30, 2022 11.51M
June 30, 2022 11.08M
March 31, 2022 10.78M
December 31, 2021 11.32M
September 30, 2021 12.08M
June 30, 2021 11.77M
March 31, 2021 10.96M
December 31, 2020 9.60M
September 30, 2020 8.712M
June 30, 2020 8.972M
Date Value
March 31, 2020 9.623M
December 31, 2019 9.923M
September 30, 2019 10.16M
June 30, 2019 9.121M
March 31, 2019 11.39M
December 31, 2018 12.77M
September 30, 2018 16.12M
June 30, 2018 18.00M
March 31, 2018 16.93M
December 31, 2017 15.34M
September 30, 2017 11.87M
June 30, 2017 11.49M
March 31, 2017 10.77M
December 31, 2016 12.01M
September 30, 2016 12.23M
June 30, 2016 12.28M
March 31, 2016 15.61M
December 31, 2015 19.51M
September 30, 2015 24.42M
June 30, 2015 28.79M
March 31, 2015 31.94M
December 31, 2014 31.34M
September 30, 2014 29.93M
June 30, 2014 26.79M
March 31, 2014 19.90M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Lite Strategy, Inc. 11.93M
AbbVie, Inc. 14.67B
Marker Therapeutics, Inc. 4.244M
TG Therapeutics, Inc. 296.46M
Rezolute, Inc. 27.48M